AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 265: E889-E897, 1993;
0193-1849/93 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lund, S.
Right arrow Articles by Pedersen, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lund, S.
Right arrow Articles by Pedersen, O.

AJP - Endocrinology and Metabolism, Vol 265, Issue 6 E889-E897, Copyright © 1993 by American Physiological Society

ARTICLES

GLUT-4 content in plasma membrane of muscle from patients with non-insulin-dependent diabetes mellitus

S. Lund, H. Vestergaard, P. H. Andersen, O. Schmitz, L. B. Gotzsche and O. Pedersen
Division of Endocrinology and Metabolism, University Clinic of Internal Medicine, Aarhus Amtssygehus, Denmark.

The abundance of GLUT-4 protein in both total crude membrane and plasma membrane fractions of vastus lateralis muscle from 13 obese non-insulin-dependent diabetes mellitus (NIDDM) patients and 14 healthy subjects were examined in the fasting state and after supraphysiological hyperinsulinemia. In the basal state the immunoreactive mass of GLUT-4 protein both in the crude membrane preparation and in the plasma membrane fraction was similar in NIDDM patients and control subjects. Moreover, in vivo insulin exposure neither for 30 min nor for 4 h had any impact on the content of GLUT-4 protein in plasma membranes. With the use of the same methodology, antibody, and achieving the same degree of plasma membrane purification and recovery, we found, however, that intraperitoneal administration of insulin to 7-wk-old rats within 30 min increased the content of GLUT-4 protein more than twofold (P < 0.01) in the plasma membrane from red gastrocnemius and soleus muscle. In conclusion, when the subcellular fractionation method was applied to human muscle biopsies taken in the basal state, no difference could be found in the plasma membrane content of immunoreactive GLUT-4 protein between NIDDM patients and normal subjects. With this technique, we were unable to show evidence for a regulatory effect of insulin on the plasma membrane level of GLUT-4 protein in human muscle.


This article has been cited by other articles:


Home page
 DiabetesHome page
M. Gaster, P. Staehr, H. Beck-Nielsen, H. D. Schrøder, and A. Handberg
GLUT4 Is Reduced in Slow Muscle Fibers of Type 2 Diabetic Patients: Is Insulin Resistance in Type 2 Diabetes a Slow, Type 1 Fiber Disease?
Diabetes, June 1, 2001; 50(6): 1324 - 1329.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. Thorell, M. F. Hirshman, J. Nygren, L. Jorfeldt, J. F. P. Wojtaszewski, S. D. Dufresne, E. S. Horton, O. Ljungqvist, and L. J. Goodyear
Exercise and insulin cause GLUT-4 translocation in human skeletal muscle
Am J Physiol Endocrinol Metab, October 1, 1999; 277(4): E733 - E741.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. P. Jones and G. L. Dohm
Regulation of glucose transporter GLUT-4 and hexokinase II gene transcription by insulin and epinephrine
Am J Physiol Endocrinol Metab, October 1, 1997; 273(4): E682 - E687.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online